
***

Additional information regarding how an esophageal cancer risk calculator and decision tool might be incorporated into clinical practice can be found in the figure (from ref #3) and following publications:  
  
1. Thrift AP, Kendall BJ, Pandeya N, Whiteman DC. A Model to Determine Absolute Risk for Esophageal Adenocarcinoma. *Clinical Gastroenterology and Hepatology* 11, 138–144.e2 (2013).

2. Thrift AP and Whiteman DC. Can we really predict risk of cancer? *Cancer Epidemiology* 37, 349–52 (2013).

3. Vaughan TL. From genomics to diagnostics of esophageal adenocarcinoma. *Nature Genetics*. 46, 806-807 (2014).  (See figure)

4. Rubenstein JH, et al. Prediction of Barrett’s esophagus among men. The American journal of gastroenterology 108, 353–62 (2013).  http://mberet.umms.med.umich.edu/
  
5. Vaughan TL and Fitzgerald RC. Precision prevention of oesophageal adenocarcinoma. *Nature Reviews Gastroenterol Hepatol* 12, 243-48 (2015).

6. Xie S-H, Lagergren, J. A Model for Predicting Individual Absolute Risk of Esophageal Adenocarcinoma: Moving towards Tailored Screening and Prevention. *Int. J. Cancer* doi:10.1002/ijc.29988 (2016).

7. Ross-Innes CS, et al. Risk stratification of Barrett’s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study. *Lancet Gastroenterol Hepatol* 2, 23–31 (2017).


The National Cancer Institute maintains a site devoted to cancer risk models: https://epi.grants.cancer.gov/cancer_risk_prediction/

***
